Clark, Stephen J.
Argelaguet, Ricard
Lohoff, Tim
Krueger, Felix
Drage, Deborah
Göttgens, Berthold
Marioni, John C.
Nichols, Jennifer
Reik, Wolf
Funding for this research was provided by:
Wellcome Trust (210754/Z/18/Z, 220379/Z/20/Z)
Biotechnology and Biological Sciences Research Council (BBS/E/B/000C0421)
Article History
Received: 16 March 2022
Accepted: 31 August 2022
First Online: 26 September 2022
Declarations
:
: Animal experimentation was approved by the Babraham Institute Animal Welfare and Ethical Review Body and complied with existing European Union and the UK Home Office legislation and local standards.
: W.R. is a consultant and shareholder of Cambridge Epigenetix. S.J.C., R.A., D.D., F.K. and W.R. are employees of Altos Labs. The remaining authors declare no competing financial interests.